Mismatched 3' Primer Ends for Telomere Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for amplifying target nucleic acids, particularly repetitive sequences like telomeres, face challenges due to primer-dimer interference, which reduces sensitivity and efficiency, and require substantial DNA quantities and time-consuming procedures.

Innovation Solution

The use of primers with altered nucleotide residues that produce mismatches when hybridizing to each other, preventing primer extension and reducing non-target amplification, allowing for specific amplification of target nucleic acids while minimizing primer-dimer products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If standard primers are used for amplifying repetitive nucleic acid sequences, then amplification can proceed, but primer-dimer products are formed that reduce sensitivity and efficiency

Engineering Contradiction:
Improveamplification sensitivityVSAvoidprimer-dimer interference
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention modifies the 3′ terminal nucleotides of primers to create mismatches that specifically prevent primer-dimer formation while preserving target hybridization. This local modification at the critical 3′ end region selectively eliminates harmful primer-primer interactions without affecting the primer's ability to bind to its complementary target sequence, thereby resolving the contradiction between maintaining amplification sensitivity and preventing primer-dimer interference

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention pre-modifies primers with altered 3′ terminal nucleotides before the amplification reaction begins. This preliminary anti-action prevents primer-dimer formation from occurring in the first place by designing primers that cannot hybridize to each other at their 3′ ends, thereby proactively eliminating the harmful effect rather than attempting to address it during the amplification process

Inventive Principle:
Principle #9Preliminary anti-action

2Manufacturing precision

If primer sequences are modified to prevent primer-dimer formation, then specificity improves, but primer design constraints increase

Engineering Contradiction:
Improveamplification specificityVSAvoidprimer design complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention changes the nucleotide parameter at the 3′ terminal position of primers by introducing deliberate mismatches. This parameter modification transforms the primer sequence to prevent complementarity with other primers while maintaining sufficient complementarity to the target. The systematic approach of modifying only the terminal nucleotides provides a straightforward method to achieve high specificity without requiring complex overall primer redesign

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention separates the primer function into distinct segments: the 5′ region maintains standard target-complementary sequences for efficient hybridization, while the 3′ terminal nucleotides are independently modified to prevent primer-dimer formation. This segmentation allows the primer to simultaneously achieve both high target specificity and low self-interaction, resolving the contradiction between amplification specificity and design complexity

Inventive Principle:
Principle #1Segmentation

3Loss of time

If indirect amplification methods are used for repetitive sequences, then primer-dimer interference is reduced, but amplification time and DNA quantity requirements increase

Engineering Contradiction:
Improveamplification procedure timeVSAvoidnon-target amplification
Core Design Contradiction:
Loss of timeVSObject-generated harmful factors

Solution Approach 1:

The invention extracts and eliminates the harmful primer-dimer formation capability from the primer molecules themselves by modifying their 3′ terminal nucleotides. This allows the use of direct amplification methods on repetitive sequences without the time-consuming indirect procedures, as the harmful non-target amplification is removed at the source while maintaining efficient target amplification

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates modified primer copies with altered 3′ terminal nucleotides that retain target-binding capability but lack primer-dimer formation capability. These modified primer copies enable direct amplification of repetitive sequences, eliminating the need for time-consuming indirect methods while preventing non-target amplification products

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid and efficient amplification of repetitive sequences, such as telomeres, with improved sensitivity and specificity, reducing the need for large DNA quantities and time-consuming procedures, and is applicable in diagnostics and disease analysis.

Implementation Method 1

a first primer hybridizes to a first strand and a second primer hybridizes to a second strand of the target nucleic acid

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

At least one nucleotide of the first primer is altered to produce a mismatch between the altered residue and the 3′ terminal nucleotide residue of the second primer when the first and second primers hybridize to each other

Methodology Applied
Scientific EffectMismatch prevention:

Implementation Method 3

The target nucleic acid is subsequently amplified by polymerase chain reaction

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS7695904B2Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
Publication Date: 2010.04.13 UNIV OF UTAH RES FOUND
  • US7695904B2 patent drawing
  • US7695904B2 patent drawing
  • US7695904B2 patent drawing

AI summary

The present invention provides for compositions and methods for amplifying target nucleic acids using nucleic acid primers designed to limit non-target nucleic acid dependent priming events. The present invention permits amplifying and quantitating the number of repetitive units in a repetitive region, such as the number of telomere repetitive units.